Five-year incidence, progression, and risk factors for age-related macular degeneration: The age, gene/environment susceptibility study

Ophthalmology

Volumn 121, Issue 9, 2014, Pages 1766-1772

  Jonasson, Fridbert ^a,b   Fisher, Diana E ^c   Eiriksdottir, Gudny ^d   Sigurdsson, Sigurdur ^d   Klein, Ronald ^e   Launer, Lenore J ^f   Harris, Tamara ^f   Gudnason, Vilmundur ^b,d   Cotch, Mary Frances ^c  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c NATIONAL EYE INSTITUTE   (United States)

^d ICELANDIC HEART ASSOCIATION   (Iceland)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f Demography and Biometry   (United States)

Author keywords

Abbreviations and Acronyms; Age, Gene Environment Susceptibility Reykjavik Study; age related macular degeneration; AGES; AMD; BMI; body mass index; GA; geographic atrophy; HDL; high density lipoprotein; high sensitivity C reactive protein; hsCRP; odds ratio; OR

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EXUDATIVE AGE RELATED MACULAR DEGENERATION; EXUDATIVE MACULAR DEGENERATION; FEMALE; FOLLOW UP; GEOGRAPHIC ATROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; SEX DIFFERENCE; SMOKING;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL, HDL; DISEASE PROGRESSION; FEMALE; GENE-ENVIRONMENT INTERACTION; HUMANS; ICELAND; INCIDENCE; MACULAR DEGENERATION; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84906934729     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.03.013     Document Type: Article

References (44)

1. R. Klein, K.E. Lee, R.E. Gangnon, and B.E. Klein Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study Ophthalmology 120 2013 1210 1219
2. C.W. Klaver, R.W. Wolfs, and J.R. Vingerling et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study Arch Ophthalmol 116 1998 653 658
3. Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States Arch Ophthalmol 122 2004 477 485
4. E. Gunnlaugsdottir, A. Arnarsson, and F. Jonasson Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study Acta Ophthalmol 86 2008 778 785
5. J.J. Wang, S. Foran, and P. Mitchell Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study Clin Experiment Ophthalmol 28 2000 268 273
6. E. Gunnlaugsdottir, A. Arnarsson, and F. Jonasson Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study Acta Ophthalmol 88 2010 358 366
7. F. Jonasson, A. Arnarsson, and H. Sasaki et al. The prevalence of age-related maculopathy in Iceland: Reykjavik Eye Study Arch Ophthalmol 121 2003 379 385
8. R. Klein, B.E. Klein, and M.D. Knudtson et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the Multi-ethnic Study of Atherosclerosis Ophthalmology 113 2006 373 380
9. R. Klein, B.E. Klein, and K.L. Linton Prevalence of age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 99 1992 933 943
10. F. Jonasson, A. Arnarsson, and T. Peto et al. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study Ophthalmology 112 2005 132 138
11. R. Klein, B.E. Klein, S.C. Jensen, and S.M. Meuer The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 104 1997 7 21
12. C.C. Klaver, J.J. Assink, and R. van Leeuwen et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study Invest Ophthalmol Vis Sci 42 2001 2237 2241
13. P. Mitchell, J.J. Wang, S. Foran, and W. Smith Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study Ophthalmology 109 2002 1092 1097
14. R. Varma, A.W. Foong, M.Y. Lai Los Angeles Latino Eye Study Group Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study Am J Ophthalmol 149 2010 741 751
15. J.J. Wang, E. Rochtchina, and A.J. Lee et al. Ten-year incidence and progression of age-related maculopathy: the Blue Mountains Eye Study Ophthalmology 114 2007 92 98
16. R. Klein, B.E. Klein, and M.D. Knudtson et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study Ophthalmology 114 2007 253 262
17. T. Aspelund, V. Gudnason, and B.T. Magnusdottir et al. Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006 PLoS ONE [serial online] 5 2010 e13957 Available at: http://www.plosone.org/article/info%3Adoi%2F10. 1371%2Fjournal.pone.0013957 Accessed March 3, 2014
18. F. Jonasson, A. Arnarsson, and G. Eiríksdottir et al. Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study Ophthalmology 118 2011 825 830
19. T.B. Harris, L.J. Launer, and G. Eiriksdottir et al. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics Am J Epidemiol 165 2007 1076 1087
20. C. Qiu, M.F. Cotch, and S. Sigurdsson et al. Retinal and cerebral microvascular signs and diabetes: the Age, Gene/Environment Susceptibility- Reykjavik Study Diabetes 57 2008 1645 1650
21. C. Qiu, M.F. Cotch, and S. Sigurdsson et al. Cerebral microbleeds and age-related macular degeneration: the AGES-Reykjavik Study Neurobiol Aging 33 2012 2935 2937
22. R. Klein, S.M. Meuer, and S.E. Moss et al. Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera Arch Ophthalmol 122 2004 1642 1646
23. R. Klein, B.E. Klein, S.C. Tomany, and K.J. Cruickschanks The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 110 2003 1273 1280
24. R. Klein, C.E. Myers, and S.M. Meuer et al. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study JAMA Ophthalmol 131 2013 383 392
25. Age-Related Eye Disease Study Research Group Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19 Ophthalmology 112 2005 533 539
26. R. Klein, M.D. Knudtson, K.J. Cruickshanks, and B.E. Klein Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study Arch Ophthalmol 126 2008 115 121
27. U. Chakravarthy, C. Augood, and G.C. Bentham et al. Cigarette smoking and age-related macular degeneration in the EUREYE Study Ophthalmology 114 2007 1157 1163
28. F. Choudhury, R. Varma, R. McKean-Cowdin Los Angeles Latino Eye Study Group Risk factors for four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study Am J Ophthalmol 152 2011 385 395
29. P.J. Barter, S. Nicholls, and K.A. Rye et al. Antiinflammatory properties of HDL Circ Res 95 2004 764 772
30. Y. Yu, R. Reynolds, and J. Fagerness et al. Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration Invest Ophthalmol Vis Sci 52 2011 4663 4670
31. S. Fauser, D. Smailhodzic, and A. Caramoy et al. Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration Invest Ophthalmol Vis Sci 52 2011 5525 5528
32. R. van Leeuwen, C.C. Klaver, and J.R. Vingerling et al. Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol 137 2004 750 752
33. J.J. Wang, E. Rochtchina, and W. Smith et al. Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort Am J Epidemiol 169 2009 633 641
34. S. Mora, R.J. Glynn, and P.M. Ridker High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy Circulation 128 2013 1189 1197
35. B.F. Voight, G.M. Peloso, and M. Orho-Melander et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study Lancet 380 2012 572 580
36. J. Ambati, J.P. Atkinson, and B.D. Gelfand Immunology of age-related macular degeneration Nature Rev Immunol 13 2013 438 450
37. J.D. Cameron, Z. Yang, and D. Gibbs et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration Cell Cycle 6 2007 1122 1125
38. E.G. Holliday, A.V. Smith, B.K. Cornes Wellcome Trust Case Control Consortium Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis PLoS ONE [serial online] 8 2013 e53830 Available at: http://www.plosone.org/article/ info%3Adoi%2F10.1371%2Fjournal.pone.0053830 Accessed March 3, 2014
39. H. Helgason, P. Sulem, and M.R. Duvvari et al. A rare nonsynonymous sequence variant in C3 is associated with high risk of age related macular degeneration Nat Genet 45 2013 1371 1374
40. J.M. Seddon, J. Cote, N. Davis, and B. Rosner Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio Arch Ophthalmol 121 2003 785 792
41. V.P. Mitta, W.G. Christen, and R.J. Glynn et al. C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts JAMA Ophthalmol 131 2013 507 513
42. A. Arnarsson, T. Sverrisson, and E. Stefánsson et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study Am J Ophthalmol 142 2006 419 428
43. J.P. SanGiovanni, E.Y. Chew, E. Agrón Age-Related Eye Disease Study Research Group The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 Arch Ophthalmol 126 2008 1274 1279
44. Age-Related Eye Disease Study 2 Research Group Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial JAMA 309 2013 2005 2015